FA58A Polyclonal Antibody

Rabbit Anti-FA58A Polyclonal Antibody

Product Specifications

Background

Mutations in CCNQ (Cyclin Q) have been shown to cause an X-linked dominant STAR syndrome that typically manifests syndactyly, telecanthus and anogenital and renal malformations. The protein encoded by CCNQ contains a cyclin-box-fold domain which suggests it may have a role in controlling nuclear cell division cycles. Alternative splicing results in multiple transcript variants encoding distinct isoforms. CCNQ is a Protein Coding gene. Diseases associated with CCNQ include Star Syndrome. An important paralog of CCNQ is CCNL1.

CAS Number

9007-83-4

Product Name Alternative

Cyclin-Q; CDK10-activating cyclin; Cyclin-M; Cyclin-related protein FAM58A

Gene ID

92002

Accession Number

Q8N1B3

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from part region of human FA58A protein at amino acid sequence of 30-110

Clonality

Polyclonal

Tag

FA58A

Applications

WB, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

27kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

The antibody detects endogenous levels of FA58A protein

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000; ELISA 1:5000-20000